HOME > ARCHIVE
ARCHIVE
- Report Highlights Growing Profitability of Matsumotokiyoshi
February 17, 2003
- Teijin Aims at \105 Bil. Pharma Sales in FY2005
February 17, 2003
- Voluntary Standards Established for Gingko Biloba, B. Natto Extracts
February 17, 2003
- Mr Nagayama Offers Proposals to Stimulate FDI in Japan
February 17, 2003
- OTC NEWS IN BRIEF
February 17, 2003
- Toyobo, Mitsui & Co Jointly Create TM Cell Research
February 17, 2003
- Takara Bio, Cepheid Launch Bead-form PCR Reagent Worldwide
February 17, 2003
- Shiro Hiruta to Take Helm of Asahi Kasei in April
February 17, 2003
- Azwell Acquires Exclusive Domestic Marketing Rights to Speculite
February 17, 2003
- Aventis Targets 25% Allergic Rhinitis Market Share for Allegra
February 17, 2003
- Fuso Gets Marketing Rights to i-STAT Blood Analysis System
February 17, 2003
- Generic Drug Use to Actively Be Promoted by Research Group
February 17, 2003
- DIAGNOSTIC NEWS IN BRIEF
February 17, 2003
- BUSINESS NEWS IN BRIEF
February 17, 2003
- MEDICAL DEVICE NEWS IN BRIEF
February 17, 2003
- Website News
February 17, 2003
- FPMAJ Considering Reshuffling of Its Member Associations
February 17, 2003
- On the move
February 17, 2003
- Press Seminar
February 17, 2003
- e-CSO to Reduce Costs: Mr Tanimura of So-net M3
February 17, 2003
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
